| 0 (0%) | 02-21 12:55 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.12 | 1-year : | 1.28 |
| Resists | First : | 0.96 | Second : | 1.1 |
| Pivot price | 0.87 |
|||
| Supports | First : | 0.74 | Second : | 0.61 |
| MAs | MA(5) : | 0.8  |
MA(20) : | 0.9 |
| MA(100) : | 1.17 |
MA(250) : | 1.6 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 13.6 |
D(3) : | 19.5 |
| RSI | RSI(14): 37.1 |
|||
| 52-week | High : | 3.08 | Low : | 0.74 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CASI ] has closed above bottom band by 20.6%. Bollinger Bands are 21.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.83 - 0.84 | 0.84 - 0.84 |
| Low: | 0.74 - 0.74 | 0.74 - 0.75 |
| Close: | 0.76 - 0.76 | 0.76 - 0.77 |
Fri, 20 Feb 2026
CASI Pharmaceuticals Closes Third Tranche of US$20 Million Convertible Note Financing - TipRanks
Thu, 19 Feb 2026
CASI Pharmaceuticals Names New Executive Chairman, Streamlines U.S. Operations Amid Listing Pressure - TipRanks
Wed, 18 Feb 2026
CASI to host annual Blarney Bash on Feb. 26 in Davenport - WQAD
Wed, 31 Dec 2025
News - CASI enhances Team Andersen understanding of strategic competitor: China - DVIDS
Thu, 27 Nov 2025
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ - Investing News Network
Tue, 25 Nov 2025
CASI's PLA Fundamentals course 3-5 February, 2026 - Air University (af.edu)
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 15 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 38.5 (%) |
| Held by Institutions | 39.2 (%) |
| Shares Short | 61 (K) |
| Shares Short P.Month | 85 (K) |
| EPS | -3.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.39 |
| Profit Margin | -184 % |
| Operating Margin | -333.2 % |
| Return on Assets (ttm) | -61.8 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -60.5 % |
| Gross Profit (p.s.) | 0.62 |
| Sales Per Share | 1.73 |
| EBITDA (p.s.) | -2.73 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.26 |
| PEG Ratio | 0 |
| Price to Book value | -0.56 |
| Price to Sales | 0.44 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|